OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy
Haijie Han, Yi Hou, Xiaohong Chen, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 10, pp. 4944-4954
Closed Access | Times Cited: 194

Showing 26-50 of 194 citing articles:

Theranostic nanoparticles with disease-specific administration strategies
Peisen Zhang, Yingying Li, Wen Tang, et al.
Nano Today (2021) Vol. 42, pp. 101335-101335
Closed Access | Times Cited: 87

Recent advances and prospects in gemcitabine drug delivery systems
Shweta Paroha, Juhi Verma, Ravindra Dhar Dubey, et al.
International Journal of Pharmaceutics (2020) Vol. 592, pp. 120043-120043
Closed Access | Times Cited: 86

Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies
Qi-Yao Wei, Yan‐Ming Xu, Andy T. Y. Lau
Cancers (2020) Vol. 12, Iss. 10, pp. 2783-2783
Open Access | Times Cited: 79

Peptide-Based Drug Delivery Systems
Dmitriy Berillo, Adilkhan Yeskendir, Zharylkasyn Zharkinbekov, et al.
Medicina (2021) Vol. 57, Iss. 11, pp. 1209-1209
Open Access | Times Cited: 78

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics
Kaido Kurrikoff, Birgit Vunk, Ülo Langel
Expert Opinion on Biological Therapy (2020) Vol. 21, Iss. 3, pp. 361-370
Open Access | Times Cited: 72

Synergistic Cancer Photochemotherapy via Layered Double Hydroxide-Based Trimodal Nanomedicine at Very Low Therapeutic Doses
Jianping Liu, Luyao Sun, Li Li, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 6, pp. 7115-7126
Closed Access | Times Cited: 72

Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma
Yanhong Liu, Jiyuan Zhou, Qiang Li, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 80-103
Closed Access | Times Cited: 72

Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2486-2486
Open Access | Times Cited: 65

Erythrocyte Membrane Camouflaged Metal–Organic Framework Nanodrugs for Remodeled Tumor Microenvironment and Enhanced Tumor Chemotherapy
Chaoqiang Qiao, Xiaofei Wang, Guohuan Liu, et al.
Advanced Functional Materials (2021) Vol. 32, Iss. 6
Closed Access | Times Cited: 59

Ferrostatin‐1‐loaded liposome for treatment of corneal alkali burn via targeting ferroptosis
Kai Wang, Li Jiang, Yueyang Zhong, et al.
Bioengineering & Translational Medicine (2021) Vol. 7, Iss. 2
Open Access | Times Cited: 59

Dual Gate‐Controlled Therapeutics for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Cancer Immunotherapy
Xiaodong Zhang, Xiaokai Chen, Yuxin Guo, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 25, pp. 14013-14021
Closed Access | Times Cited: 57

Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines
Meng Li, Yijing Zhang, Qin Zhang, et al.
Materials Today Bio (2022) Vol. 16, pp. 100364-100364
Open Access | Times Cited: 55

Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
Zhaoyu Ma, Heyou Han, Yanli Zhao
Biomaterials (2022) Vol. 293, pp. 121947-121947
Open Access | Times Cited: 49

Remediating Desmoplasia with EGFR‐Targeted Photoactivable Multi‐Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer
Girgis Obaid, Shazia Bano, Hanna Thomsen, et al.
Advanced Science (2022) Vol. 9, Iss. 24
Open Access | Times Cited: 43

Physically stimulus-responsive nanoparticles for therapy and diagnosis
Fatemeh Farjadian, Soheila Ghasemi, Mohsen Akbarian, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 43

Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment
Yunkun Li, Yahui Wu, Zaixiang Fang, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 41

Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress
Zhe Sun, Jinhai Huang, Zvi Fishelson, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1971-1971
Open Access | Times Cited: 34

Reversing Acute Kidney Injury through Coordinated Interplay of Anti‐Inflammation and Iron Supplementation
Ruixue Duan, Yueping Li, Ruru Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 28
Closed Access | Times Cited: 30

Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Yi Pan, Longcai Liu, Xiaozhou Mou, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 20875-20924
Closed Access | Times Cited: 26

Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13

Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management
Yifan Zhou, Mingyu Xu, Wenyue Shen, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 10

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4087-4101
Open Access | Times Cited: 9

Scroll to top